IDARUCIZUMAB vs IMATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IDARUCIZUMAB vs IMATINIB: Safety Overview
| Metric | IDARUCIZUMAB | IMATINIB |
|---|---|---|
| Total FAERS Reports | 1,562 | 43,161 |
| Deaths Reported | 1,014 | 13,761 |
| Death Rate | 64.9% | 31.9% |
| Hospitalizations | 570 | 7,264 |
| Average Patient Age | 77.6 yrs | 55.7 yrs |
| % Female Patients | 42.7% | 47.2% |
| FDA Approval Date | N/A | Apr 14, 2025 |
| Manufacturer | Boehringer Ingelheim Pharmaceuticals,... | Dr.Reddy's Laboratories Inc |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Discontinued |